ABSTRACT Diet and lifestyle factors, body size, and smoking behavior may influence estrogen metabolism, but the nature of these relations may vary according to race/ethnic groups. We evaluated the association of lifestyle factors with estrogen metabolites 2-hydroxyestrone (2-OHE1) and 16a-hydroxyestrone (16a-OHE1) in a racially diverse population. With a cross-sectional study design, urine samples from 1881 African-American, Caucasian, Chinese, Japanese, and Hispanic women, aged 42-52 y, from the Study of Women's Health Across the Nation (SWAN) were assayed by EIA for 2-OHE1 and 16a-OHE1. Dietary factors and beverages were measured using a modified Block FFQ. Dietary fiber, vegetable and fruit servings, Brassica vegetables, polyphenols, coffee, caffeine, green and black tea, and total alcohol and wine were related to metabolite values using multiple variable regression analyses. In adjusted analyses, 2-OHE1 concentrations were significantly associated with race/ethnicity, weight, smoking, and consumption of hydroxybenzoic acid, anthocyanidins, wine, and caffeine (P , 0.05). Regression models incorporating these variables explained 19-20% of the variation in 2-OHE1 concentrations. Regression models for 16a-OHE1, which explained 16-17% of the variability, included race/ethnicity, smoking, caffeine, total dietary fiber, and fiber from fruits and vegetables as variables. These associations may reflect why increased consumption of polyphenol-containing foods and fruit as well as decreased smoking, caffeine intake, and body size would be consistent with hypothesized benefits and risks for selected health outcomes. J. Nutr. 136: 1588Nutr. 136: -1595Nutr. 136: , 2006 KEY WORDS: estrogen metabolism polyphenols isoflavones caffeine body size Lifestyle practices, including dietary and beverage consumption, can influence estrogen metabolism as reflected in the urinary excretion of 2-hydroxyestrone (2-OHE1) 3 and 16a-hydroxyestrone (16a-OHE1). Understanding the contribution of lifestyle factors to estrogen catabolism is important because 16a-hydroxyestrogens appear to retain substantial estrogenic activity through covalent binding to the estrogen receptor (1) and histone proteins (2). Further, the 2-hydroxyestrogens may act as antioxidants (3). A growing appreciation of the potential physiological effect of these metabolites has developed, leading investigators to evaluate their contribution to variation in breast cancer frequency (4), bone mineral density levels (5), and oxidized LDL cholesterol concentration, an important contributor to the atherogenic process (6).
Lifestyle practices, including dietary and beverage consumption, can influence estrogen metabolism as reflected in the urinary excretion of 2-hydroxyestrone (2-OHE1) 3 and 16a-hydroxyestrone (16a-OHE1). Understanding the contribution of lifestyle factors to estrogen catabolism is important because 16a-hydroxyestrogens appear to retain substantial estrogenic activity through covalent binding to the estrogen receptor (1) and histone proteins (2) . Further, the 2-hydroxyestrogens may act as antioxidants (3) . A growing appreciation of the potential physiological effect of these metabolites has developed, leading investigators to evaluate their contribution to variation in breast cancer frequency (4) , bone mineral density levels (5) , and oxidized LDL cholesterol concentration, an important contributor to the atherogenic process (6) .
It is unclear whether race/ethnic differences in estrogen metabolism are independent of the contribution of lifestyle variation (7). For example, the prevalence of smoking behavior has marked race/ethnic variation (8) , and smoking may increase induction of the 2-hydroxylation metabolic pathway (7). Physical activity patterns are also differentially reported by race/ ethnic groups, and intense physical activity is associated with an increased likelihood of 2-hydroxylation of estrogen metabolites (9) .
The type of dietary macronutrient intake may influence excreted estrogen metabolites. For example, chimpanzees whose dietary fat intake was increased from 15 to 65% of total energy intake had increased 16a-OHE1 and decreased 2-OHE1 excretion (10) . In some (11), but not all studies (12), women who were switched from a diet of 40 to 25% of energy from fat had less excretion of 16a-estrogen metabolites. A high-protein diet may enhance 2-hydroxylation of estradiol (13) . Consumption of cruciferous (Brassica) vegetables such as cabbage, Brussels sprouts, and broccoli may be associated with the downregulation of the cytochrome P450 (CYP)1A1 enzyme (14) which is associated with 2-hydroxylation of estrone or alteration of the 2:16 hydroxyestrone ratio (15) . Selected flavonoids in citrus fruits (i.e., naringenin, kaempferol, limogen, and quercetin) may also affect the CYP450 system enzymes, which are important in estrogen metabolism (16) .
We examined the relation of diet and lifestyle factors to urinary 2-OHE1 and 16a-OHE1 concentrations in 1881 middleaged African-American, Caucasian, Chinese, Hispanic, and Japanese women living in the United States as the first stage in determining how behaviors are related to estrogen metabolism in a manner that may affect health outcomes. The following questions were addressed: 1) Are intakes of food products such as servings of fruits and vegetables, caffeine and beverages, macronutrients (i.e., fiber) or polyphenols (including subgroups such as isoflavones) associated with 2-OHE1 or 16a-OHE1 concentrations? 2) Are measures of body size, cigarette smoke exposure, or physical activity associated with 2-OHE1 concentrations or with 16a-OHE1 concentrations? 3) Do differences in lifestyle factors explain the racial/ethnic variation in 2-OHE1 or 16a-OHE1 concentrations?
As a secondary activity, we described race/ethnic variation in dietary food and nutrient intake.
SUBJECTS AND METHODS

Sampling and study population
This report includes data from 1881 (430 African-American, 945 Caucasian, 213 Chinese, 71 Hispanic, 222 Japanese) pre-and perimenopausal women from the Study of Women's Health Across the Nation (SWAN), a community-based, longitudinal study of the menopausal transition (17) . Participants were enrolled at 7 clinical sites in Boston MA, Chicago IL, the Detroit area of MI, Los Angeles CA, Hudson County NJ, Oakland CA, and Pittsburgh PA. Study eligibility criteria for enrollment in the SWAN longitudinal cohort were as follows: age 42-52 y; intact uterus and at least 1 ovary; no current use of estrogens or other medications known to affect ovarian function at baseline; at least 1 menstrual period in the 3 mo before enrollment; and self-identification as a member of 1 of the 5 eligible racial/ethnic groups. Each site enrolled a Caucasian sample; additionally, each site enrolled a sample of non-Caucasian women, including African-American women in Boston, Chicago, the Detroit area, and Pittsburgh, and Japanese, Chinese, and Hispanic women in Los Angeles, Oakland, and New Jersey, respectively. Institutional Review Board approval for the study protocol and informed consent were obtained at each study site (University of Michigan; Massachusetts General Hospital; Rush University; University of California, Davis; University of California, Los Angeles; New Jersey Medical School; University of Pittsburgh).
Measures
Dietary data were obtained from a modified Block interviewerassisted FFQ (18) , administered in 4 languages (English, Spanish, Chinese, or Japanese) that obtained ''usual'' dietary pattern for the previous year. The English-language FFQ version contained a 103-item core food list. The Hispanic, Chinese, and Japanese ethnic group versions included the 103-item core food list plus 9, 12, and 16 additional culturally specific foods, respectively. Serving sizes were reported with the assistance of food models. Daily dietary intake values for energy, dietary protein, fat, carbohydrates, dietary fiber (which is expressed as total daily intakes and source-specific intakes, including fiber from beans, grains, fruits, and vegetables), vegetable and fruit servings, and servings of coffee, wine, beer, liquor, green tea, and black tea were taken from the FFQ and its associated dietary database (18) .
The FFQ was administered to participants throughout the study year, minimizing the likelihood of a seasonal effect.
Brassica vegetable servings and antioxidant fruit and vegetable servings were calculated from the raw food frequency data. Cabbage, broccoli, cauliflower, Brussels sprouts, and kale were grouped as the most commonly consumed members of the Brassica family of vegetables. The antioxidant vegetable group included kale, spinach, Brussels sprouts, alfalfa sprouts, broccoli, beets, red bell pepper, onion, corn, and eggplant. The antioxidant fruit group included prunes, raisins, blueberries, blackberries, strawberries, raspberries, plums, oranges, red grapes, cherries, kiwi, and pink grapefruit. The results for these food groups are reported as numbers of servings per day.
Polyphenol values from Manach et al. (19) were assigned to foods and beverages by using the midpoint of the published range (in mg of the particular polyphenol/serving) for an average daily serving estimated from the FFQ (Appendix 1). Some food or beverage items on the FFQ could contribute to more than one polyphenol subgroup; thus, decision rules were developed for their assignment. For example, the FFQ groups all berries together as a single item; however, only blueberries contribute hydroxycinnamic acid. Because blueberry consumption is limited, berries were not assigned to the hydroxyannamic acid subgroup. In contrast, several types of berries assessed with the FFQ (strawberries, blackberries and raspberries) include hydroxybenzoic acids; therefore, the mean number of berry servings was assigned a daily hydroxybenzoic acid intake value. Isoflavone values included daily genistein and daidzein intakes that had been estimated previously from the FFQ and database using information from Reinli (20) . USDA tables were used as the reference source for the hot chili peppers included in the Spanish version of the FFQ.
Coffee and caffeine consumption were estimated separately. The estimate of overall caffeine consumption excluded caffeine from coffee. Coffee and caffeine consumption were not included in the total polyphenol value or the amount of hydroxycinnamic acids because their consumption greatly exceeded other sources of polyphenols. Diet and beverage categories were based on empirical distribution among the participants.
Total alcohol consumption per day was categorized as none, ,7.1 g (,0.25 oz), 7.1-14.2 g (0.25-0.50 oz), and at least 14.2 g (0.50 oz). Wine consumption was evaluated separately and categorized as none, no more than 0.50 serving/d, and .0.50 serving/d.
Other lifestyle variables. Weight (kg) was measured using balance beam scales, and height (m) was measured using stadiometers. Data on active and passive smoke exposure were obtained from a selfadministered questionnaire incorporating American Thoracic Society questions (21) and validated questions on passive exposure (22) , respectively. Number of cigarettes per day was categorized as 0, 1-9 (less than a half-pack), 10-19 (at least a half-pack but less than a pack), and 201 (at least a pack). Total weekly hours of passive smoke exposure at home, work, or in other public/social settings was categorized into quartiles for nonzero values, with a 5th category for no exposure. Baseline leisure physical activity was based on the frequency, intensity, and duration of the 2 sports or exercise activities reported by the participant as occurring in the year before assessment (23) . Possible physical activity scores ranged from 1 to 5.
Estrogen metabolites. The estrogen metabolites 2-OHE1 and 16a-OHE1 were assayed in urine collected during a first morning void at the first annual follow-up visit (n ¼ 1729); however, annual core specimen collection protocols at 2 of the sites did not include urine. To obtain this type of sample at these 2 sites, urine samples (n ¼ 152) collected as part of the protocol for the SWAN Daily Hormone SubStudy (DHS) were selected and assayed. DHS urine samples were collected during the early follicular stage of the menstrual cycle to be consistent with the timing of samples collected at the annual visit.
2-OHE1 and 16a-OHE1 were assayed by EIA (ESTRAMETä) in triplicate (24) ; values were corrected for creatinine. The inter-and intra-assay CV were ,10% for each analyte over the assay range of 2.09-139.6 mmol/L. Urinary forms of 2-OHE1 and 16a-OHE1 are found as 3-glucuronides or mixtures of 3-and 16-glucuronides and sulfates. The estrogen metabolites were deconjugated from glucuronic acid and sulfate to achieve recognition by the monoclonal antibodies using a mixture of b-glucuronidase and arylsulfatase enzyme isolated from the snail Helix pomatia.
Serum estradiol (E 2 ) concentrations were measured with a modified, off-line ACS:180 (E 2 -6) immunoassay (Bayer Diagnostics). Inter-and intra-assay CV were 10.6 and 6.4%, respectively, over the assay range of 73.42 to 1835.5 pmol/L. Because the blood was drawn during the early follicular phase of the menstrual cycle, the assay range was calibrated to address the lower E 2 values. Less than 1% of the study participants had transitioned to menopause at the first annual follow-up visit. Because E 2 is a source of the metabolites of interest, early follicular E 2 values were included in modeling, serving as a proxy for menopause status.
Statistical approach
Analyses were conducted using SAS Version 8.0 statistical software. Diet information came from the baseline administration of the FFQ. Other data were collected at the first follow-up visit because urine samples for analyses of the estrogen metabolites were available only from the first follow-up visit. Data were excluded from this report for any of the following reasons: loss from the baseline enrollment of 3302 women due to attrition (n ¼ 453) or surgical menopause (n ¼ 9), use of exogenous reproductive hormone therapy at the first follow-up visit (n ¼ 212), missing estrogen metabolite data because the protocol at 2 sites did not include urine collection (n ¼ 593), missing serum E 2 levels (n ¼ 9), missing baseline dietary data (n ¼ 99), and missing number of cigarettes smoked (n ¼ 14) or passive smoke exposure hours (n ¼ 50). The final analytical sample included 1881 participants: 430 African-American, 945 Caucasian, 71 Hispanic, 213 Chinese, and 222 Japanese women.
Means 6 SE were calculated for continuous variables, including 2-OHE1 and 16a-OHE1, serum E 2 , weight, and age. Dietary variable distributions were expressed as medians and interquartile ranges (IQR ¼ difference between the 75th and the 25th percentiles) to account for the highly skewed nature of the distributions of these variables. Continuous variables were log-transformed, as appropriate, to satisfy the normality assumption in parametric testing. In multivariate regression, explanatory factors were categorized to accommodate the nonlinear associations with hormone metabolites.
ANOVA with F-tests were used to evaluate potential differences between race/ethnic groups. Differences in dietary data that were not normally distributed were evaluated using the Kruskal-Wallis test. Analyses of covariance (ANCOVA) were used to determine the associations between dietary and lifestyle variables and the estrogen metabolites. Partial Spearman correlations were estimated to describe relations between the dietary variables and the estrogen metabolites. Dietary variables were evaluated singly rather than simultaneously to avoid collinearity.
In models with 2-OHE1 as the outcome variable, serum E 2 , weight, age, race/ethnicity, and kilojoules of energy (dietary models only) were included as covariates; in models with 16a-OHE1 as the outcome variable, the covariates were serum E 2 , age, race/ethnicity, and kilojoules of energy (dietary models only). Unadjusted and adjusted analyses showed that 16a-OHE1 was not related to weight. Interactions between weight and E 2 , weight and race/ethnic group, and dietary factors were evaluated, but a significant interaction was observed only between race/ethnicity and weight. Therefore, only the model evaluating the association between weight and 2-OHE1 included that interaction term.
P-values from the correlations used to characterize statistical significance in initial variable selection for multivariate modeling were two-sided at a , 0.10; 95% CI were used to describe associations from ANCOVA models.
RESULTS
Urinary 2-OHE1 and 16a-OHE1 levels varied among race/ ethnic groups ( Table 1 ). The concentration of 2-OHE1 in Caucasian women was 55.6 mmol/L, which was significantly higher than those of Japanese, Chinese, and Hispanic women. African-American women had the highest 16a-OHE1 concentration (34.9 mmol/L), which was significantly higher than all other race/ethnic groups. Hispanic and Japanese women had the lowest concentrations of both 2-OHE1 (37.3 and 37.8 mmol/L, Table 1 ). The total polyphenol profile of Japanese and Chinese women was markedly different from that of Hispanic, Caucasian, and African-American women ( Table 2 ). This was driven by the increased consumption of monomeric flavanols and isoflavones (including genistein and daidzein). Further, the median consumption of isoflavones was twice as great in Japanese women compared with Chinese women [previously reported by Huang et al. (25) ]. Hispanic women consumed fewer foods with hydroxybenzoic acids and anthocyanidins. Additionally, race/ethnic differences were notable in consumption of the macronutrients (energy in kilojoules, protein, fat, carbohydrates), and amounts of fiber, fruits and vegetables, and polyphenol subgroups shown in Table 2 .
2-OHE1 metabolite concentrations. Weight (kg) was significantly and inversely associated with 2-OHE1 levels (P 5 0.0015). The associations of diet and lifestyle factors with 2-OHE1 ( Caffeine intake (excluding caffeine from coffee) was independently and significantly positively related to 2-OHE1 in a regression model (Table 3) . Women in the highest quartile of caffeine consumption (at least 319 mg/d) had a higher 2-OHE1 (39.1 mmol/L) than those who consumed #67.1 mg caffeine/d (31.8 mmol/L), the lowest quartile of intake. The association with wine was not monotonic, with the highest 2-OHE1 concentration in the middle category; this association remained significant with multivariate adjustment. Coffee intakes and green tea consumption were not related to 2-OHE1 levels after adjustment for covariates.
Foods rich in hydroxybenzoic acids (i.e., berries) and anthocyanidins (i.e., berries and cabbage) comprised the 2 polyphenol subgroups whose consumption was significantly and positively associated with 2-OHE1.
16a-OHE1 metabolite concentrations. Smoking was associated with 16a-hydroxyestrone concentrations in models adjusted for E 2 concentrations, age, and race (Table 3) . 
DISCUSSION
Understanding the sources of variation in estrogen metabolites is important because of their potential associations with breast cancer (4), as well as levels of bone mineral density (5) and oxidized LDL cholesterol (6) . We chose to focus our study on the individual metabolites 2-and 16a-hydroxyestrone but not the 2:16 hydroxyestrone ratio because, biologically, the metabolites have potentially distinct roles, including antioxidant and receptor ligand binding capacities (4, 5, 26) . The 16-hydroxylated metabolite is well-defined by its ability to bind with and engage in signal transduction through the estrogen receptor (27) . In contrast, the role of the 2-hydroxylated metabolite is less well-defined.
African-American women had a significantly lower 2:16 hydroxyestrone ratio than Caucasian women, consistent with other reports (28, 29) . We found that Chinese and Japanese women were relatively similar to each other but different from Caucasian women as also reported by Aldercruetz et al. (30) . Importantly, the association of metabolites with race/ethnicity existed independently of body size, smoking behavior, and dietary consumption, which might influence estrogen metabolism. It remains to be determined whether these race/ethnic differences in estrogen metabolites are related to a differential presentation of disease frequencies and symptoms by race/ethnic group. Most research on these disease associations occurs in Asian populations, but our data suggest the importance of also including African-American women in future studies. Body size, reflected in weight (results are similar with and without adjustment for height), can influence the estrogen metabolite pool through increased aromatization of androgens to estrogens by adipocytes (31). Coker et al. (29) reported that obese women were more likely to have lower 2:16a-hydroxyestrone ratios than nonobese women. We found that obese women were more likely to have lower 2-OHE1, a relation we cannot explain. Only a modest rise was observed in 16a-OHE1 with increased weight and this was not significant. This suggests that the observation by Coker et al. (29) was, in large measure, due to lower 2-hydroxyestrone concentrations. Because of the importance of body size to the estrogen metabolite pool, physical activity might also be an important mediator. Intense physical activity is associated with an increased likelihood of 2-hydroxylation of estrogen metabolites (32, 33) . In unadjusted analyses, there was a modest positive increase in 2-OHE1 with increasing physical activity score and no association with 16a-OHE1; however, these associations were not significant when adjusted for weight and race/ethnicity.
Nonsmokers had lower 2-OHE1 and 16a-OHE1 concentrations than smokers with no dose-response among the smokers. This is in contrast to the report of Jernström et al. (34) on premenopausal women in which smokers and nonsmokers (or number of cigarette packs smoked) did not differ after adjustment for age, ethnicity, menstrual status, and oral contraceptive use (34) . Because smokers are generally 10-15 pounds (4.5-6.8 kg) lighter than nonsmokers (35), we considered an interaction between smoking status and body size in relation to the estrogen metabolites but there was no significant interaction.
Our adjusted analyses indicated that caffeine (from chocolate, tea, and cola beverages but excluding caffeine from coffee), was associated with both estrogen metabolites; in contrast, Jernström et al. (34) reported that higher coffee consumption was significantly associated with higher levels of 2-OHE1 and nonsignificantly negatively associated with 16a-OHE1 (34) . We speculate that the CYP450 enzymes responsible for the conversion of estrone to the metabolites of interest (CYP1A1 and CYP1B1) may be induced by increased caffeine intake, which is consistent with the long-time practice of using caffeine as a challenge test for enzyme systems (36, 37) .
An alcohol-induced rise in estrogens is a consequence of alcohol catabolism in the liver (38) . Interestingly, this rise was particularly noted around the periovulatory and luteal phase of the menstrual cycle (39). We did not see an association between alcohol consumption and the estrogen metabolites in the follicular phase in our adjusted analyses. Potentially, we might have seen a pattern had the urine samples for this study been collected in the luteal phase of the menstrual cycle. Wine consumption, however, was modestly associated with 2-OHE1 levels in adjusted analyses. Red wine, but not white wine, was reported to negatively affect the activity of the CYP450 enzyme aromatase, suppressing the conversion of androgens to estrogens (40) .
This study is distinctive in examining classes of carboxylic acid derivatives of compounds with a phenolic ring system (including hydroxybenzoic and hydroxycinnamic acids). Hydroxybenzoic acids occur primarily as glycosides in which hydroxycinnamic acids appear as simple esters. In these chemical classes, the phenolic hydroxyl moiety may be stoichiometrically positioned in the estrogen receptor to mimic the C3-hydroxyl location on the steroid A ring, which is responsible for activation of the receptor (41) . Other heterocyclic phenols, widely designated as phytoestrogens, have structures analogous to human estrogens and bind to the estrogen receptors a and b to stimulate transcriptional activity (42,43). We evaluated specific estimates of genistein and diadzein, the main compounds of the isoflavone class of phytoestrogens (44) found in soybeans and soy-derived foods such as tempeh, miso, and tofu. There was no association with genistein and diadzein, consistent with the report by Martini et al. (45) but in contrast to Xu et al. (46) who reported that moderate soy protein consumption was associated with decreased amounts of 16a-OHE1.
Within this study, food products thought to have antioxidant activity, including hydroxybenzoic acid and anthocyanidins, were more likely to be related to higher levels of 2-OHE1. Polyphenols were positively associated with variation in 2-OHE1 concentrations, whereas fiber intakes were negatively associated with 16a-OHE1. It is almost axiomatic that a high-fiber diet diminishes estrogen absorption from the intestinal lumen (47) and that binding of unconjugated estrogens to fiber in the gut impedes their reabsorption (48) . Increased fiber intake has been associated with less bioavailable estradiol (49) . Dietary fiber intake and plasma estradiol concentrations were negatively correlated in a study of premenopausal Asian immigrant and Caucasian women (50). Types of fiber have different effects, and the effect may or may not reflect the contribution of other dietary constituents. For example, significant reductions in serum estrogen concentrations were reported in premenopausal women supplemented with wheat bran, but not in those supplemented with oat or corn bran, all of which doubled dietary fiber consumption without reducing fat intake (47) .
The indole content of Brassica vegetables (including Brussels sprouts, broccoli, cabbage, kale, turnips, collards and cauliflower) was studied as a protective mechanism against breast cancer (51). However, not all studies, including those with an intercountry orientation, identified a protective effect with Brassica vegetable consumption for breast cancer (52, 53) . One explanation may be the amount of Brassica vegetable consumed. The mean consumption in our study was less than one-third serving per day, which is probably insufficient to provide detectable protection.
The capabilities and limitations of this study must be considered. Food intakes, estimated from the FFQ, may be imprecisely recalled by respondents with respect to serving size and frequency of consumption, resulting in misclassification. Errors can arise from limitations in existing food composition databases for polyphenols, missing food sources, and failure to account for the variation generated by soil content in which crops are grown or the processing/cooking to which the foods are subjected (20, 54) . Although this study included a single urine sample for metabolite assessment, measures of 2-OHE1 and the 16a-OHE1 have a high within-woman correlation of 0.85. SWAN also incorporated strategies to minimize the effect of measurement error, including collection of urine within d 2-5 of the onset of menses when estrogen production was lowest and the ratio of estradiol to estrone was most consistent.
In summary, this study confirms the importance of race/ ethnicity in characterizing estrogen metabolism among middleaged women. The current data demonstrate that selected selfreported fiber, antioxidant, and polyphenol intake, as well as weight, smoking, and caffeine intake were associated with the urinary concentrations of estrogen metabolites. Further, there appeared to be more variation in 2-OHE1 explained by environmental factors than 16a-OHE1. This assessment suggests that it may be beneficial to increase consumption of polyphenolcontaining foods and fruit as well as to decrease smoking, caffeine intake, and body size; this would be consistent with hypothesized benefits and risks for specific health outcomes.
